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Considerable effort has been expended to determine whether the gene for angiotensin I–converting enzyme (ACE)
confers susceptibility to cardiovascular disease. In this study, we genotyped 13 polymorphisms in the ACE gene
in 1,343 Nigerians from 332 families. To localize the genetic effect, we first performed linkage and association
analysis of all the markers with ACE concentration. In multipoint variance-component analysis, this region was
strongly linked to ACE concentration (maximum LOD score 7.5). Likewise, most of the polymorphisms in the
ACE gene were significantly associated with ACE ( ). The two most highly associated polymorphisms,P ! .0013
ACE4 and ACE8, accounted for 6% and 19% of the variance in ACE, respectively. A two-locus additive model
with an additive # additive interaction of these polymorphisms explained most of the ACE variation associated
with this region. We next analyzed the relationship between these two polymorphisms (ACE4 and ACE8) and
blood pressure (BP). Although no evidence of linkage was detected, significant association was found for both
systolic and diastolic BP when a two-locus additive model developed for ACE concentration was used. Further
analyses demonstrated that an epistasis model provided the best fit to the BP variation. In conclusion, we found
that the two polymorphisms explaining the greatest variation in ACE concentration are significantly associated
with BP, through interaction, in this African population sample. Our study also demonstrates that greater sta-
tistical power can be anticipated with association analysis versus linkage, when markers in strong linkage dis-
equilibrium with a trait locus have been identified. Furthermore, alllelic interaction may play an important role
in the dissection of complex traits such as BP.
Introduction
The genes of the renin-angiotensin system (RAS) have
been subjected to the most intense molecular scrutiny of
any regulatory pathway in cardiovascular disease
(CVD). The discovery early on that an Alu element was
strongly associated with circulating levels of ACE (MIM
106180) provided a convenient genetic marker (Rigat et
al. 1990; Tiret et al. 1992). Several studies of CVD phe-
notypes have suggested that the D allele from the inser-
tion/deletion (I/D) polymorphism within the ACE gene
confers increased risk for CVD (Evans et al. 1994, Sou-
brier et al. 1994). At the same time, considerable neg-
ative evidence exists on this question. An analysis of
11,000 cases and controls showed no relationship be-
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tween myocardial infarction and the I/D polymorphism
(Keavney et al. 2000). The I/D marker was likewise un-
associated with myocardial infarction in Italian and
French population samples (Arca et al. 1998; Ferrieres
et al. 1999). O’Malley et al. (1999) summarized the as-
sociation between the I/D polymorphism and CVD risk,
grouping studies by geographical region and disease
prevalence. In this analysis the ACE I/D polymorphism
did not appear to be a clinically useful indicator of risk
for myocardial infarction.
Hypertension is an important risk factor for CVD.
As has been the case for myocardial infarction, conflict-
ing results have been reported regarding the associa-
tion between the I/D polymorphism and blood pressure
(BP) (Schmidt et al. 1993; Morise et al. 1994; Barley et
al. 1996; Vassilikioti et al. 1996; Borecki et al. 1997).
Two large population-based studies found, for BP and
the I/D polymorphism, marginally significant associa-
tion and linkage evidence, which were restricted to
males (Fornage et al. 1998; O’Donnell et al. 1998).
Recently, a genome-scan analysis by The Framingham
Heart Study found strong evidence for a quantitative-
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trait locus (QTL) on chromosome 17, which was close
to theACE gene and was linked to BP (Levy et al. 2000).
Whether the ACE polymorphisms account for BP var-
iation is, therefore, very much undecided.
Negative findings in prior studies may be due to the
inadequate power to detect the modest contribution
from an individual gene to a trait such as BP. Further-
more, analyses based on single polymorphisms in can-
didate genes can lead to false-negative outcomes for
complex traits. Therefore, a more thorough understand-
ing of the total genomic variation that exists in a region,
as well as of the effect that these variants have on the
intermediate pathways, may be necessary. Only after all
the genetic and physiological information has been ex-
hausted can definitive conclusions be made regarding a
candidate’s role in complex phenotypes such as hyper-
tension and heart disease. To this end, we genotyped an
informative set of 13 single-nucleotide polymorphisms
(SNPs), across the entire ACE gene, in a sample of Ni-
gerian families. A series of models were fitted, to identify
the polymorphisms causing the variation in plasma ACE
concentration. These polymorphisms were then used in
further analyses, to assess the contribution that theACE
gene makes to BP variation.
Subjects and Methods
Recruitment of Subjects
The sampling frame for this study was provided by the
International Collaborative Study on Hypertension in
Blacks, as described in detail elsewhere (Cooper et al.
1997; Guo et al. 1999; Rotimi et al. 1999). During the
first phase of the study, sample surveys were conducted
in residential communities in western Africa (Nigeria and
Cameroon), the Caribbean (Barbados, St. Lucia, and Ja-
maica) and the United States (metropolitan Chicago)
(Cooper et al. 1997). In the second phase, nuclear families
were identified through middle-aged probands, and all
available first-degree relatives were enrolled (Guo et al.
1999; Rotimi et al. 1999). In the present article, we report
the findings from Nigeria. The enrolled families included
1,993 persons; analyses were restricted to the set of 1,343
individuals in 332 families for whom both measurements
of ACE concentration and genotype data were available.
Study protocols were reviewed and approved by the re-
view boards of the participating institutions.
ACE Measurement
Determination of ACE concentration was performed
by a previously published “sandwich” enzyme-linked
immunosorbent assay (Danilov et al. 1996), with some
modifications. In brief, plasma samples diluted 1/10
were incubated in polystyrene microtiter plates coated
with monoclonal antobody to ACE 9B9. After unbound
human plasma was washed off, the ACE plates were
incubated with sheep anti-ACE IgG (kindly provided by
Dr. S. Pokrovsky, National Cardiology Research Center,
Moscow) conjugated with peroxidase. The plates were
washed again, and bound peroxidase was quantified by
diaminobenzidine (Sigma) at 492 nm on a microplate
reader. The interassay coefficient of variation was 5.6%,
and the intraassay coefficient was 6.2%, on the basis of
60 samples. Some concern arose about the possibility
that Nigerian samples had defrosted because electrical
power there had been intermittent when they were col-
lected; however, freeze-thaw experiments did not suggest
that values of ACE would have been falsely elevated
under those conditions.
For the majority of samples, DNA was extracted from
buffy coats at the University of Utah, by a standard phe-
nol-chloroform procedure, and was brought to a standard
concentration of 20 mg/ml. For the remaining samples,
DNA was extracted in Oxford, by the Masterpure ge-
nomic DNA–purification kit, which uses a rapid desalting
process to remove contaminating macromolecules.
Genotyping
The 11 diallelic SNPs listed in table 1 were all typed
by PCR amplification, followed by restriction-enzyme
digestion, with, where necessary, an artificial restriction
site introduced by primer mismatch (see table 1). PCR
products were digested with the appropriate restriction
enzyme (table 1), according to the manufacturer’s pro-
tocol. Digested products were run on agarose gels,
stained with ethidium bromide, and scored by UV vi-
sualization. With the exception of ACE4 and ACE5, all
SNPs were amplified by the same procedure. Genomic
DNA was amplified in a 15-ml reaction containing 25
ng of DNA, 0.3 mM of each primer, 0.125 mM of each
dNTP, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), and 0.25
U of AmpliTaqGold (PE Biosystems), with MgCl2 con-
centrations as in table 1. Cycling conditions were 95C
for 15 min; followed by 35 cycles of 94C for 30 s,
annealing at the appropriate temperature (TA) (see table
1) for 30 s, and 72C for 30 s; and, finally, a 10-min
extension at 72C.
The following procedure was used to amplify ACE4
and ACE5: The region spanning both markers was am-
plified by primers ACE5F2 and ACE5R, in a 50-ml re-
action containing 100 ng of genomic DNA, 0.3 mM of
each primer, 0.125 mM of each dNTP, 50 mM (NH4)2
SO4, 2.5 mM MgCl2, 10% glycerol, 4 U of AmpliTaq
(PE Biosystems). Cycling conditions were 95C for 1min
30 s; then 10 cycles of 95C for 1 min, 65C (0.5C/
cycle) for 1 min, and 72C for 3 min; and then 30 cycles
of 95C for 1 min, 60C for 1 min, and 72C for 3 min.
A 1:25 dilution of the resulting product was then used
as a template to amplify the region containing ACE4,
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in a 25-ml reaction containing 0.3 mM of each primer,
0.125 mM of each dNTP, 50 mM (NH4)2SO4, 1 mM
MgCl2, 1 U of AmpliTaq (PE Biosystems). Cycling con-
ditions were 95C for 1min 30 s; then 35 cycles of 95C
for 1 min, 55C for 1 min, and 72C for 3 min; and
then 72C for 10 min (table 1).
For the I/D polymorphism, the primers listed in table
1 were used to amplify the region of Alu insertion, with
the Alu element’s presence or absence being detected by
running the product on an agarose gel. PCR amplifi-
cation was performed in a 15-ml reaction containing 25
ng of DNA, 0.45 mM of each primer, 0.125 mM of each
dNTP, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 0.25 U
of AmpliTaq Gold (PE Biosystems), and 3 mM MgCl2.
The cycling conditions were 95C for 15 min; then 35
cycles of 94C for 1 min, 62C for 45 s, and 72C for
1 min; and, finally, 72C for 10 min.
The dinucleotide polymorphism 21288(TC)2/3, ACE9,
was typed by a quasimultiplex strategy. Seven different-
sized, fluorescently labeled PCR products were first gen-
erated by the following distinct combinations of six
primers: (1) 333 bp, ACE9FB and ACE9RA (see table
1); (2) 305 bp, ACE9FB and ACE-VIL-9R (GCTACA-
CTCCAGCGTCTGAGG); (3) 296 bp, ACE9FA (C-
ATTTCCACTGGCAGTGGA) and ACE9RA; (4) 268
bp, ACE9FA and ACE-VIL-9R; (5) 205 bp, ACE-VIL-
9F (GAGTACCTTGGAGGGCCTGCT) and ACE9RA;
(6) 177 bp, ACE-VIL-9F and ACE-VIL-9R; and (7) 130
bp, ACE-COL-9F (TTGGCTCCTGCTGTACCAG) and
ACE9RA. The PCR protocol used was that described
above for all the SNPs, except ACE4 and ACE5, and
size refers to the larger allele—for example, 21288(TC)3.
A mixture of the seven different-sized products, plus a
size standard, were then run on an ABI 377 automated
sequencer (seven products per lane), with allele sizes
scored by GENOTYPER software.
Statistical Analyses
Descriptive statistics were calculated by means of SAS
(SAS Institute). The allele frequencies for each SNP were
calculated by the allele-counting method. Hardy-Wein-
berg equilibrium at each locus was assessed by the x2 test
with 1 df (Weir 1996). We used the variance-component
approach in GENEHUNTER to test for linkage between
a genetic location and ACE concentration, systolic BP
(SBP), and diastolic BP (DBP). The variance-component
method specifies the expected genetic covariancesbetween
relatives, as a function of their identity-by-descent (IBD)
relationships at a marker locus (Pratt et al. 2000). The
IBD probabilities are derived from available genotyped
marker loci. The likelihood-ratio test is applied to test the
null hypothesis of no additive genetic variance due to the
QTL. Sex, age, and age2 were incorporated as covari-
ates, and their effects were estimated simultaneously by
the maximum-likelihood method. The multipoint linkage
analysis is dependent on the marker distances and the
marker order—which, if there are any genotype errors in
such a short genome region, can be inconsistent with the
distances transformed on the basis of base pairs and the
sequence order. We then conducted single-point linkage
analysis using SIBPAL2. In this program, the mean-cor-
rected trait product is linearly regressed on the estimated
proportion of alleles that the sib pair shares IBD at each
marker locus (Elston et al. 2000).
Measured genotype analysis accounting for familial
aggregation and covariate effects was performed by the
computer program ASSOC, available in the Statistical
Analysis for Genetic Epidemiology package (S.A.G.E.
2000). The ASSOC program is designed to evaluate the
association between a continuous trait and a discrete
genetic marker, by means of a mixed-effect model pro-
posed by George and Elston (1987). The model treats
the genetic marker and covariates as fixed effects and
treats the familial effect among relatives as a random
effect, together with a random individual environmental
effect. The familial effect is modeled on the assumption
that the residual correlations between pairs of family
members are due entirely to polygenic effects. Herita-
bility is estimated without the use of genetic marker in-
formation. We used the delta method to estimate the
standard error of the heritability.
To test the association between a genetic marker and
a phenotype, ASSOC uses the maximum-likelihood sta-
tistic: 2(maximum loge likelihood under the general
model  maximum loge likelihood under the null hy-
pothesis). This statistic, under the assumptions of trans-
formability to normality and the null hypothesis, is
asymptotically distributed as a x2 distribution. The ap-
propriate number of degrees of freedom is given by the
difference between the numbers of parameters estimated
when the likelihoods are maximized under the null and
alternative hypotheses.
In this study, ACE was first analyzed under the as-
sumption of an additive, dominant, or recessive mode
of inheritance at each marker locus. Since we had 13
markers, adjustment for multiple comparisons was nec-
essary; a value of was conservatively consid-P ! .0013
ered to be genetically significant, being equivalent to the
nominal value .05 if all 39 tests were independent. The
most significant marker associated with ACE was iden-
tified, and this marker was then considered as a covariate
in the model, to identify the second most significant
marker. We then adjusted for these two markers, to test
whether the other markers could account for any further
variation in ACE. The best two-marker model, including
possible interaction between the two markers, was iden-
tified, and this model was used to test association with
SBP and DBP. Because, to test for association with BP,
we decided beforehand to use the best model associated
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Table 2
Demographic Characteristics of Study Participants
Male Female
No. (%) 696 (51.8) 647 (48.2)
Mean age  SE (years) 41.6  20 40.1  18.5
Mean BMI  SE (kg/m2) 20.3  3.6a 22.1  4.8
Mean ACE  SE 612.6  223.4 605.3  209.8
Mean SBP  SE 126.3  24.7a 129.4  29.6
Mean DBP  SE 75.8  17.0a 78.4  18.4
a Significantly different ( ) between males and females,P ! .05
when subjects are assumed to be independent.
Table 3
Pearson Correlation Coefficients among Phenotype
Measures
TRAIT
PEARSON CORRELATION COEFFICIENT (SE) FOR
BMI SBP DBP
ACE .103 (.0002) .041 (.14) .085 (.002)
BMI .265 (.0001) .349 (.0001)
SBP .836 (.0001)
with ACE, a value of was considered to be sta-P ! .05
tistically significant. Finally, an epistasis model was de-
fined for BP, to evaluate possible interactions between
markers.
Results
The demographic characteristics of the participants are
reported in table 2. No individuals were taking medica-
tion that might have modified BP levels. The mean ages
of men and women were similar, but women had nom-
inally significantly higher levels of BMI, SBP, and DBP,
compared with men. ACE concentrations were not sig-
nificantly different between the two genders. Correlations
among the phenotypes (i.e., ACE, BMI, SBP, and DBP)
are presented in table 3; no correlation between ACE and
SBP was observed, and only a weak correlation between
ACE and DBP was observed ( ).FDF ! .1
Polymorphisms at 13 sites were genotyped across a
27-kb segment in the ACE gene (fig. 1). No significant
deviations from Hardy-Weinberg equilibrium were
found among the sites tested, except at sites ACEs2.1
and ACE6 ( and , respectively). ThePp .05 Pp .03
genetic analyses were performed with sex, age, and age2
included as covariates. The overall heritability (h2) val-
ues for ACE, SBP, and DBP were estimated to be
, , and , respectively, after.65 .01 .42 .02 .46 .05
the significant covariates were taken into account. Mul-
tipoint linkage analysis was conducted in this region for
the three phenotype measures. For ACE, a maximum
LOD score of 7.5 was observed close to marker ACE8;
a second peak, of 7.2, was seen at the site close to ACE5.
The multipoint LOD score for both SBP and DBP was
always !0.1. The single-point linkage analysis by SIB-
PAL2 showed weak evidence of linkage between SBP
and ACE2 and between SBP and ACE7 ( andPp .06
, respectively); no significant evidence of linkagePp .08
between DBP and ACE polymorphisms was found
( ). These results thus provide strong evidencePp .29
that, in this region, there is at least one ACE-related
QTL but minimal evidence for linkage between genetic
variation and BP.
Association with ACE Concentration
We then performed association analysis at each of the
13 markers, with age and gender as covariates and under
the assumption of an additive, recessive, or dominant
mode of inheritance, in separate analyses. Figure 2 pre-
sents the P values from the likelihood-ratio tests. Only
the smallest P values among the three different modes
of inheritance are reported. The vertical axis gives the
log10(P) for testing no association between ACE con-
centration and the marker. The dotted horizontal line
represents (log[.0013]p 2.886 ), the levelPp .0013
at which comparisons become significant at the 5% level
after adjustment for multiple comparisons. The poly-
morphisms meeting this criterion included ACE1, ACE2,
ACE4, ACE7, I/D, and ACE8 ( ) (fig. 2, lineP ! .0013
with black triangles). The highest peaks were observed
at markers ACE8 and ACE4, explaining 19% and 6%
of the total variance, respectively. To determine whether
the association with ACE, which was found at the six
polymorphisms, was due to linkage disequilibrium be-
tween them, we repeated the analysis after adjusting for
the effect at ACE8. With this adjustment, the association
at markers ACE7 and I/D was no longer significant, but
it did remain so at markers ACE1, ACE2, ACE3, and
ACEs2.1 (fig. 2, dashed line with black circles). Similar
results were found in an analysis stratified by genotype,
at ACE8. Similarly, we performed the same analysis,
adjusting for ACE4; the association with ACE was then
no longer significant for markers ACE1, ACE2, and
ACE3 but did remain significant for markers ACE7, I/
D, ACE8, and ACE9 (fig. 2, dashed line with crosses).
In essence, the association disappears at the markers
close to the adjusted polymorphism but remains at the
more distant markers. We then adjusted for polymor-
phisms ACE4 and ACE8 simultaneously. The resulting
log10(P) fell below the level of significance, everywhere
except at ACE3, ACEs2.1, and ACE9 (fig. 2, dashed line
with black squares). In addition, thelog10(P) increased
for ACE3, ACEs2.1, and ACE9, after adjustment for
ACE4 and ACE8; this result may have occurred because
ACE4 and ACE8 may not be the functional mutations
themselves but, instead, are in linkage disequilibrium
(LD) with functional variants. In addition, it is possible
that variants that are not in strong LD with either ACE4
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Figure 1 Schematic representation of the human ACE (DCP1)
gene. Lines in the upper portion of the graph represent the polymor-
phisms typed in this study, with positions characterized by use of “1”
to represent the first nucleotide of the first codon (AGT) in exon 1.
Figure 2 Results of association analysis relating ACE concen-
tration to variants in the ACE gene. Age and gender were entered as
covariates; additive, recessive, or dominant modes of inheritance were
assumed in separate analyses, but only the smallest P value among the
three different modes of inheritance is reported. P values are from the
likelihood-ratio test with 1 df. The dotted horizontal line represents
( ), the 5%-significance level after ad-Pp .0013  log [.0013]p 2.886
justment for multiple comparisons.
or ACE8 may have effects on ACE concentrations. Over-
all, these findings suggest that most of the ACE variation
in this region can be explained by variants in the gene,
at sites close to the ACE4 and ACE8 polymorphisms.
We then defined the best ACE model as the one that
accounted for the greatest proportion of the variance
when ACE4, ACE8, and their interaction were consid-
ered together. After the testing of all the combinations
of additive, dominant, and recessive modes of inheri-
tance, for ACE4 and ACE8 jointly, the model that in-
cluded ACE4 and ACE8 as additive, together with the
“additive # additive” interaction term, was identified as
the best ACE model, explaining 22% of the total vari-
ance. The best model also agreed with that selected on
the basis of Aikake’s information criterion (AIC) (AIC
p 2 ln likelihood  2[no. of independently estimated
parameters]). The A allele of the ACE4 polymorphism
was associated with increased ACE concentration, as
was the G allele of the ACE8 polymorphism.
Association with BP
To test the hypothesis that ACE QTLs also affect SBP
and/or DBP, we performed association analyses, using
the best ACE model described above. The regression
results from the program ASSOC are presented in table
4. (We omitted age2 from the model for SBP because it
was not significant.) With gender, age, and BMI as covar-
iates, both ACE4 and ACE8 were significantly associated
with SBP ( ); The average level of SBP increasedP ! .05
2.3 and 3.2 mmHg with each copy of allele T and G
present, respectively. Only the ACE4 polymorphism was
significantly associated with DBP ( ), yielding aP ! .05
1.5-mmHg increase for each copy of the allele T. Sur-
prisingly, the alleles at the ACE4 polymorphism had the
opposite effect with regard to ACE concentration and
BP—the T allele was associated with a decrease in ACE
concentration and with an increase in BP.
Since the T allele at ACE4 and the G allele at ACE8
were associated with increasing BP, we defined an epis-
tasis model as one in which BP will be increased only
when both the T and G alleles are present (table 5). This
model was significant for both SBP and DBP (Pp
and , respectively; see table 5), predicting.005 Pp .04
∼5-mmHg-higher and ∼2-mmHg-higher values for SBP
and DBP, respectively, in persons with both the T and
G alleles, compared with those with neither of these
alleles. Because the best ACE model according to ACE
concentrations and the epistasis model are not nested
within each other, we used the AIC to compare them.
From tables 4 and 6, we conclude that the epistasis
model is slightly better than the best ACE model derived
directly from the analysis of ACE concentrations.
We performed the same analyses separately, by gender,
using the epistasis model. A significant association with
SBP was found among women ( ) but notPp .007
among men, whereas no association with DBP was
found in either gender. Of course, this last null finding
could be due to the reduction of the sample size. We
also conducted the analysis with only a single SNP in
the model and found that ACE8 is associated with SBP
( ). Finally, we tested the remaining sites andPp .04
found no associations with either SBP or DBP ( ;P 1 .05
data not shown). We repeated all the analyses of SBP
and DBP, after including ACE as an additional covariate,
and obtained essentially the same results.
Discussion
We have conducted linkage and association analyses
based on markers in the ACE candidate region on chro-
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Table 4
Regression Coefficients for SBP and DBP, for the Best Genetic Model, on the Basis of ACE Concentration
REGRESSION COEFFICIENT (SE) FOR
Sex Age Age2 BMI ACE4 (Ta) ACE8 (Ga) ACEA # ACE8 AIC
SBP (mmHg) 2.91 (1.41)b .68 (.04)c … .99 (.17)c 2.34 (1.14)b 3.2 (1.36)b 3.4 (2.0) 10,192.4
DBP (mmHg) 1.23 (.90) .41 (.02)c .009 (.001)c .82 (.12)c 1.50 (.73)b .99 (.87) 1.35 (1.29) 9,192.2
a Allele increases SBP or DBP.
b Statistically significant at .P ! .05
c Statistically significant at .P ! .01
Table 5
Epistasis Model
ACE4
ACE8
AA AG GG
AA 0 0 0
AT 0 1 1
TT 0 1 1
NOTE.—The model indicates that BP levels
are increased when both the T allele at ACE4
and the G allele at ACE8 are present.
mosome 17 in a large population-based sample of fam-
ilies. Unlike previous studies, which, for genetic infor-
mation, relied solely on the I/D polymorphism, we
genotyped 13 polymorphisms in the ACE gene simulta-
neously. In a sequential analytic strategy, we used ACE
concentration as the first phenotype and BP as the second.
Two SNPs were identified that accounted for the variation
of ACE concentration. The polymorphism in intron 17,
ACE8, had the most significant effect, accounting for 19%
of the total variance in ACE. The second polymorphism,
ACE4, was located in the 5′ section of the gene and ac-
counted for 6% of the variance. The effects of both of
these polymorphisms best fitted an additive model. After
adjustment for the effect of ACE8, the I/D polymorphism
was no longer associated with ACE, indicating that it is
in LD with ACE8 and unlikely to be a functional mu-
tation. Our study therefore provides positive evidence that
there are two single-nucleotide variants, separated by 12
kb, which define a genomic region influencing ACE con-
centration. This result is consistent with previous reports
in a European population (Villard et al. 1996), in which
functional variants at the 3′ and 5′ ends of the ACE gene
were reported. Zhu et al. (2000) did not test the 5′ poly-
morphisms in Europeans and Afro-Caribbeans, but their
significant finding in the 3′ region agrees with the results
of the present study. We also found that the A allele at
ACE4 increased ACE concentration in our sample but
has been reported to be associated with decreased ACE
concentration in British and French populations (Villard
et al. 1996; Keavney et al. 1998). These discrepant find-
ings suggest that ACE4 is not the functional polymor-
phism but is in strong LD with the relevant ACE variants.
In fact, in our sample, with regard to ACE concentration,
all the alleles at polymorphisms ACE1–ACE4 have an
effect that is opposite to what was seen in the European
sample (data not shown), suggesting that ACE1–ACE4
themselves are unlikely to be the functional mutants af-
fecting ACE concentration.
When the best-fitting model for ACE concentra-
tion—a model based on the markers designated
“ACE4” and “ACE8”—was used, a significant associ-
ation with BP was also found. An epistasis model—that
is, one taking into account the potentially interactive
effect of the two genetic loci—best fits the data. When
both the G allele at ACE8 and the T allele at ACE4
were present, SBP and DBP increased, on average, by
5 and 2 mmHg, respectively. The size of the allelic effect
derived from this model is substantial, relative to most
genotype-phenotype relationships thus far described for
BP; on the other hand, despite both the large amount
of information available from the 13 polymorphisms
and the LOD score of 17 for ACE concentration, the
evidence of linkage between the ACE locus and BP was
hardly significant. In addition, we found more linkage
evidence by using single-point linkage analysis than by
using multipoint linkage analysis. Because we studied a
small chromosomal region, genotyping errors leading
to inconsistent physical distances or marker order could
potentially reduce the sensitivity of multipoint linkage
analysis and dilute the linkage evidence. Furthermore,
the polymorphism that we typed explained only 1% of
the variance in BP, yet the association result was rea-
sonably powerful. This result is consistent with the
greater statistical power that can be anticipated from
association analysis compared with linkage analysis,
when markers that are in LD with the trait locus have
been identified. However, replication of these results is
required to confirm that our finding is not due to type
I error.
Two recent epidemiological studies have also reported
a relationship between the I/D marker and BP, although
the findings were marginally significant and restricted to
males (Fornage et al. 1998; O’Donnell et al. 1998). For-
nage et al. studied a young adult white population sample
that was untreated for hypertension (Fornage et al.
1998). The disadvantage of a young sample, of course,
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Table 6
Regression Coefficients and Wald Test P Values for the Epistasis Model, for SBP and DBP
REGRESSION COEFFICIENT (WALD TEST P VALUE) FOR
Sex Age Age2 BMI ba AIC
Entire sample:
SBP 2.88 (1.41)b .67 (.04)c … .99 (.17)c 5.1 (1.82)c 10,189.1
DBP 1.23 (.90) .41 (.02)c .009 (.001)c .82 (.12)c 2.4 (1.16)b 9,188.1
Males:
SBP … .49 (.04)c … 1.77 (.25)c 4.4 (2.43) …
DBP … .34 (.03)c .009 (.002)c 1.25 (.17)c 2.7 (1.55) …
Females:
SBP … .94 (.06)c … .47 (.23)b 7.1 (2.65)c …
DBP … .49 (.04)c .008 (.002)c .57 (.16)b 2.66 (1.73) …
a As defined by the epistasis model in table 5. A positive value indicates the increment of BP level when the T allele at ACE4
and the G allele at ACE8 are present.
b Statistically significant at .P ! .05
c Statistically significant at .P ! .01
is the possible reduction in power to detect hypertension
genes when the trait has not been fully expressed.
O’Donnell et al. (1998) performed linear regression anal-
yses of SBP and DBP by adjusting for antihypertensive
treatment in a large sample from The Framingham Heart
Study. Considering antihypertensive treatment as a covar-
iate for adjustment may create potential bias, however,
because of the correlation between the treatment and the
genes affecting BP variation. We did not replicate these
male-specific findings. In our study, a significant associ-
ation was found between the interaction of A240T and
G2350A and BP, but this result was significant in females
only when gender-specific analyses were performed. The
null finding in men may be due to the decrease in sample
size, since all the P values were close to .05.
The RAS has always been an attractive model system
for the study of the genetics of hypertension, because
the intermediate phenotypes can be measured directly.
On the basis of the hypothesis that, over the course of
a lifetime, even small increases in RAS activity elevate
risk of hypertension in some individuals, ACE concen-
tration should be a guide to the genetic makeup that
conditions that risk. This model system is therefore well
suited to a sequential approach that first uses linkage
analysis to define the informative variants on the basis
of the intermediate phenotype and then uses association
analysis with BP as the ultimate phenotype. Although,
in the present study, this strategy has appeared to work
well for ACE, most candidate genes do not have a read-
ily assayed intermediate phenotype. As a further cor-
ollary of this argument, linkage alone may be an inef-
fective strategy if the impact that other loci have on BP
is as small as that which we have observed for ACE.
As noted above, the allelic effect for ACE4 is opposite
in direction for ACE concentration and BP. This finding
is obviously inconsistent with the simple “overactivity”
hypothesis put forward above. We have no immediate
explanation for this result. These complex interrelation-
ships could, in part, explain the low correlation between
ACE and BP, and could suggest, if confirmed, that there
are common—but functionally different—ACE variants
affecting both ACE and BP variation. This result may
also help explain the conflicting findings in previous stud-
ies (Schmidt et al. 1993; Morise et al. 1994; Barley et al.
1996; Vassilikioti et al. 1996), since only the I/D poly-
morphism was considered in the association with hy-
pertension; for example, we found ACE8 marginally as-
sociated with SBP when we tested each marker singly.
In general, the power to detect a gene will increase
with information on multiple loci and their interactions.
Our study is the first to consider more than one ACE
polymorphism in the analysis of BP variation. The result
confirms the need to consider multiple loci and allelic
interactions—and, possibly, gene # environmental in-
teractions, if they can be characterized—in the study of
complex traits such as hypertension.
The families studied here were recruited as part of an
international collaborative project examining the ge-
netic and environmental factors that have resulted in
the large population shifts in BP that have been seen
across the African diaspora (Cooper et al. 1997, 1999).
Despite the lower prevalence of hypertension observed
in rural Nigeria, several advantages for family studies
in that society are present. Nuclear families tend to be
larger, and many of them live close together in adult-
hood. Furthermore, at the first screening encounter, no
antihypertensive treatment was observed, given the low
level of screening and detection, and BP could be used
as a quantitative trait for all individuals. (Within the
limitations of a research project, treatment subsequently
was provided for newly detected cases.)
Whether these findings will apply to industrialized
societies such as the United States remains an open ques-
tion. In previous analyses, we have shown that the re-
lationships among BP, environmental exposures, and
the components of the RAS vary substantially across
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African-origin populations in the United States, the Car-
ibbean, and West Africa (Cooper et al. 1998, 1999,
2000; Kaufman et al. 1997). In general, the relationship
between BP and both the environmental and physio-
logical factors is stronger in the low-risk, Nigerian set-
ting, suggesting that multiple exposures destabilize the
regulatory systems. This general pattern could also ap-
ply to genetic relationships, throwing them into sharper
relief. Whatever the modifying effects, it is still reason-
able to assume that the variation in the nature of these
relationships, from low- to high-risk environments, is
one of degree and not one of kind.
In conclusion, in our large population-based sample,
we found strong evidence of two SNPs in the ACE gene
that are associated with circulating-ACE concentration.
These two polymorphisms also significantly affect BP
level through interaction. If confirmed, these results
would support the “RAS hypothesis” of hypertension
predisposition and would help to reconcile previous,
inconsistent findings.
Acknowledgments
We wish to acknowledge the facilities provided by the Well-
come Trust Centre for Human Genetics, under the direction
of Dr. G. M. Lathrop, and, specifically, the assistance provided
by Roger Cox and his laboratory, especially the work by Alison
Hughill. This work was supported by an internal grant from
the University of Oxford, and by National Heart, Lung, and
Blood Institute grants HL45508 and HL 47910, National In-
stitute of General Medical Sciences grant GM28356, and Na-
tional Center for Research Resources grant RR03655.
Electronic-Database Information
The accession number and URL for data in this article are
as follows:
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for ACE [MIM 106180])
References
Arca M, Pannitteri G, Campagna F, Candeloro A, Montali A,
Cantini R, Seccareccia F, Campa PP, Marino B, Ricci G
(1998) Angiotensin-converting enzyme gene polymorphism
is associated with coronary atherosclerosis and myocardial
infarction in a sample of Italian patients. Eur J Clin Invest
28:485–490
Barley J, Blackwood A, Miller M, Markandu ND, Carter ND,
Jeffer S, Cappuccio FP, MacGregor GA, Sagnella GA (1996)
Angiotensin converting enzyme gene I/D polymorphism blood
pressure and the renin-angiotensin system in Caucasian and
Afro-Caribbean peoples. J Hum Hypertens 10:31–35
Borecki IB, Province MA, Ludwig EH, Ellison RC, Folsom
AR, Heiss G, Lalouel JM, Higgins M, Rao DC (1997) As-
sociation of candidate loci angiotensinogen and angiotensin-
converting enzyme with severe hypertension: the NHLBI
Familiy Heart Study. Ann Epidemiol 7:13–21
Cooper R, Forrester T, Ogunbiyi O, Mufunda J (1998) An-
giotensinogen levels and obesity in four population samples.
J Hypertens 16:571–576
Cooper RS, Guo X, Rotimi CR, Luke A, Ward R, Adeyemo
A, Danilov S (2000) Heritability of angiotensinogen and
ACE: a comparison of Nigerian and African-American fam-
ily sets. Hypertension 35:1141–1147
Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B,
Kadiri S, Muna W, Kingue S, Fraser H, Forrester T, Bennett
F, Wilks R (1997) Hypertension prevalence in seven popu-
lations of African origin. Am J Public Health 87:160–168
Cooper RS, Rotimi CN, Ward R (1999) The puzzle of hyper-
tension in African Americans. Sci Am 280:56–63
Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow
L, Alhenc-Gelas F (1996) Development of enzyme-linked
immunoassays for human angiotensin I converting enzyme
suitable for large-scale studies. J Hypertens 14:719–727
Elston RC, Buxbaum S, Jacobs KB, Olson IM (2000) Haseman
and Elston revisited. Genet Epidemiol 19:1–17
Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T,
Crane J, O’Rourke DF, Cambien F (1994) Polymorphisms
of the angiotensin-converting-enzyme gene in subjects who
die from coronary heart disease. Q J Med 87(4): 211–214
Ferrieres J, Ruidavets JB, Fauvel J, Perret B, Taraszkiewicz D,
Fourcade J, Nieto M, Chap H, Puel J (1999) Angiotensin I-
converting enzyme gene polymorphism in a low-risk Eu-
ropean population for coronary artery disease. Atheroscle-
rosis 142:211–216
Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle
E (1998) Variation in the region of the angiotensin-con-
verting enzyme gene influences interindividual differences
in blood pressure levels in young white males. Circulation
97:1773–1779
George VT, Elston RC (1987) Testing the association between
polymorphic markers and quantitative traits in pedigrees.
Genet Epidemiol 4:193–201
Guo X, Rotimi C, Cooper R, Luke A, Elston R, Ward R, Ogun-
biyi O (1999) Evidence of a major gene effect for angioten-
sinogen among Nigerians. Ann Hum Genet 63:293–300
Kaufman JS, Asuzu MC, Sparks H, Mufunda J, Luke A, Rotimi
CN, Cooper RS (1997) The relationship between blood pres-
sure and body mass index in lean populations. Hypertension
30:1511–1517
Keavney B, McKenzie C, Connell JMC, Julier C, Ratcliffe PJ,
Sobel E, Lathrop M, Farrall M (1998) Measured haplotype
analysis of the angiotensin-1 converting enzyme (ACE) gene.
Hum Mol Genet 7:1745–1751
Keavney B, McKenzie C, Parish S, Palmer A, Clark S, Young-
man L, Delepine M, Lathrop M, Peto R, Collins R (2000)
Large-scale test of hypothesised associations between the
angiotensin-converting-enzyme insertion/deletion polymor-
phism and myocardial infarction in about 5000 cases and
6000 controls: International Studies of Infarct Survival (ISIS)
Collaborators. Lancet 355:434–442
Levy D, DeStefano AL, Larson MG, O’Donnell CJ, Lifton RP,
Gavras H, Cupples AC, Myers RH (2000) Evidence for a
gene influencing blood pressure on chromosome 17: genome
scan linkage results for longitudinal blood pressure phe-
notypes in subjects from The Framingham Heart Study. Hy-
pertension 36:477–483
Morise T, Takeuchi Y, Takeda R (1994) Angiotensin-convert-
1148 Am. J. Hum. Genet. 68:1139–1148, 2001
ing enzyme polymorphism and essential hypertension. Lan-
cet 343:125
O’Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas
JM, Schaefer EJ, Myers RH, Levy D (1998) Evidence for
association and genetic linkage of the angiotensin-converting
enzyme locus with hypertension and blood pressure in men
but not women in The Framingham Heart Study. Circulation
97:1766–1772
O’Malley JP, Maslen CL, Illingworth DR (1999) Angiotensin-
converting enzyme and cardiovascular disease risk. Curr
Opin Lipidol 10:407–415
Pratt SC, Daly MJ, Kruglyak L (2000) Exact multipoint quan-
titative-trait linkage analysis in pedigrees by variance com-
ponents. Am J Hum Genet 66:1153–1157
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubri-
er F (1990) An insertion/deletion polymorphism in the an-
giotensin I-converting enzyme gene accounting for half the
variance of serum enzyme levels. J Clin Invest 86:1343–1346
Rotimi CN, Cooper RS, Cao G, Ogunbiyi O, Ladipo M, Owoaje
E, Ward R (1999) Maximum-likelihood generalized herita-
bility estimate for blood pressure in Nigerian families. Hy-
pertension 33:874–878
S.A.G.E. (2000) Statistical analysis for genetic epidemiol-
ogy, release 4.0. Department of Epidemiology and Biosta-
tistics, Rammelkamp Center for Education and Research,
MetroHealth Campus, Case Western Reserve University,
Cleveland
Schmidt S, Van Hooft IM, Grobbee DE, Ganten D, Ritz E (1993)
Polymorphism of the angiotensin I converting enzyme gene
is apparently not related to high blood pressure: Dutch Hy-
pertension and Offspring Study. J Hypertens 11:345–348
Soubrier F, Nadaud S, Williams TA (1994) Angiotensin I con-
verting enzyme gene: regulation, polymorphism and impli-
cations in cardiovascular diseases. Eur Heart J 15:24–29
Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F,
Soubrier F (1992) Evidence, from combined segregation and
linkage analysis, that a variant of the angiotensin I-con-
verting enzyme (ACE) gene controls plasma ACE levels. Am
J Hum Genet 51:197–205
Vassilikioti S, Doumas M, Douma S, Petidis K, Karagiannis
A, Balaska K, Vyzantiadis A, Zamboulis C (1996) Angio-
tensin converting enzyme gene polymorphism is not related
to essential hypertension in a Greek population. Am J Hy-
pertens 9:700–702
Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubri-
er F (1996) Identification of new polymorphisms of the an-
giotensin I-converting enzyme (ACE) gene, and study of their
relationship to plasma ACE levels by two-QTL segregation-
linkage analysis. Am J Hum Genet 58:1268–1278
Weir BS (1996) Genetic data analysis II. Sinauer Associates,
Sunderland, MA
Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel
U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder
MJ (2000) Localization of a small genomic region associated
with elevated ACE. Am J Hum Genet 67:1144–1153
